Behavioral data indicate substantial underuse: ~40% delay epinephrine and 56% of caregivers fear needle-based auto-injectors, ...
Canada has approved neffy, a needle-free epinephrine nasal spray for severe allergies. Learn about its 30-month shelf life ...
This approval addresses a critical need for Canadians affected by severe allergies that put them at risk of anaphylaxis,' the ...
From probiotics to do-it-yourself IgG test kits, social media is misinforming patients about how to diagnose and manage ...
Health Canada has approved use of the brand neffy, the first needle-free treatment for some allergic reactions — such as ...
In any case, if you’re familiar with epinephrine, there’s a recall worth having on radar. On Tuesday, the FDA published a ...
New Mexico Attorney General Raúl Torrez announced that the State of New Mexico has reached a $2.25 million settlement with ...
Abello Pharmaceuticals Inc. Canada (ALK Canada) today announced that Health Canada has approved neffy® 2 mg for the ...
TORONTO — Health Canada has approved the first needle-free epinephrine treatment for severe allergic reactions: a nasal spray ...
New Mexico Attorney General Raúl Torrez said the state reached a $2.25 million settlement over claims a pharmaceutical ...
Canada for adults and children (>30 kg) living with severe allergic reactions ALK- Abelló A/S, which licenses the rights to market neffy in Canada, expects availability in the summer of 2026 SAN DIEGO ...
Staff at Emplify Health by Bellin are now training to recognize anaphylaxis and use epinephrine in an emergency. For three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results